Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/18/2019
Moffitt Cancer Center CEO, Others Resign Over China Ties
12/18/2019
HitGen and Mitsubishi Tanabe Enter Into License Agreement
12/17/2019
NMPA/CDE Commits to CDISC Standards
12/17/2019
Janssen and Shandong Fontacea Enter Licensing Deal for Anti-IL17A mAb
12/17/2019
NHSA Issues Interim Regulation for Government Information Publication
12/17/2019
NMPA: China Has Over 1 Mln Registered Pharmacists
12/16/2019
NHSA and NHC Issue Joint Notice to Facilitate BMI Access of Negotiated...
12/16/2019
NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018
12/16/2019
BeiGene's Brukinsa Fails to Match AbbVie-J&J Rival Imbruvica in La...
12/16/2019
A Few Details on the US-China "Phase One" Trade Deal
12/16/2019
The US-China Trade Deal Phase Two - Digital Trade, IP, Cyber Intrusion...
12/13/2019
Recent Executive Moves
12/13/2019
BeiGene Announces Clinical Data on Anti-PD-1 Tislelizumab in Combo wit...
12/13/2019
ZJ Medicine and Ambrx Present Positive Data from a Phase 1a/1b Trial o...
12/13/2019
Preview of 16 Heavy-weight New Drug Expected to be Approved in China N...
12/13/2019
IQVIA: Chinese Hospital Drug Market Up 9.7% in MAT Q3/2019
12/12/2019
Eli Lilly's Verzenio and Amgen's Blincyto To Be Granted Priority Revie...
12/12/2019
Astrazeneca Rounds Out Stellar China Year - And Beats Roche To The Pun...
12/12/2019
Numab and 3SBio's Subsidiary Form Partnership to Develop Novel Multi-s...
12/12/2019
AstraZeneca Granted Chinese Approval of Imfinziin for Unresectable Sta...
12/11/2019
Avantor Opens Center in Shanghai to Boost Biopharma Innovation in Chin...
12/11/2019
Harbin Pharmaceutical Group Poised to Take Over Ailing GNC
12/10/2019
National Drug Usage Monitoring Platform Becomes Operational
12/10/2019
SAMR Solicits Public Comments on the Provisions for Registration of Dr...
12/10/2019
China Cuts Prices For 70 More Drugs After Talks with Pharmaceutical Fi...
12/9/2019
PingAn Good Doctor and Merck Sign Agreement to Explore Integrated Heal...
12/9/2019
Samsung Bioepis Approved to Initiate Phase 3 Trial of Trastuzumab Bios...
12/6/2019
NHSA Issues New Policy for Drug Price Regulation
12/6/2019
Recent Executive Moves
12/6/2019
Innovent Announces First Patient Dosed in Phase I Trial of Anti-LAG-3 ...
Page:
126
/
357
Total number of articles:
10690
:
[First]
[<<]
[124]
[125]
[126]
[127]
[128]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit